Delivery Order SPE2DB24D3013-SPE2DB24FFHAL

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,578.00 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, on August 23, 2024, with a completion date of August 26, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,435.82, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on May 3, 2024, with a completion date of May 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $1,578.00 with a firm fixed price pricing type and a completion date of September 6, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,751.31 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with an ultimate completion date of November 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a ceiling value of $2,630.00 and a completion date of August 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,578.00 and a completion date of April 30, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,147.42 firm fixed price contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 3, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), which is a defense agency. The contract, valued at $2,698.64, was awarded to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,841.00, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical and medical products to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,156.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 6, 2024. The contract was not designated with a set-aside...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHAL
    Delivery Order

This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,419.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024. The contract has a completion date of August 19, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and the company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the supply of a broad range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support military treatment programs and other government healthcare initiatives.

Generated 11/15/24, 9:28 AM